Raltegravir potassium salt ≥98%, solide cristallin
Fournisseur: Cayman Chemical
|
Danger
|
CAYM16071-5EA
267
CHF
CAYM16071-5
CAYM16071-10
CAYM16071-50
CAYM16071-1
Raltegravir potassium salt ≥98%, solide cristallin
Raltegravir potassium salt
Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM).
It is metabolised primarily by uridine diphosphate glucuronosyltransferase 1A1. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.
Formule:
C₂₀H₂₀FKN₆O₅ MW: 482,51 g/mol température de stockage: Réfrigérateur |
MDL Number:
MFCD12031642 Numéro CAS: 871038-72-1 |
Résultats des tests de spécification
Purity | ≥98% |
λmax | 210, 312 nm |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...